市場調査レポート

商品コード

1401910

非侵襲的モニタリングデバイス市場の2030年までの予測：タイプ別、適応症別、エンドユーザー別、地域別の世界分析

Non Invasive Monitoring Device Market Forecasts to 2030 - Global Analysis By Type, By Indication, By End User and By Geography

出版日: 2023年12月01日 | 発行: Stratistics Market Research Consulting

| ページ情報: 英文 200+ Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,150 650,554円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 822,990円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 995,426円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,175,700円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の非侵襲的モニタリングデバイス市場は2023年に44億米ドルを占め、予測期間中のCAGRは10.8％で成長し、2030年には91億米ドルに達する見込みです。

非侵襲的モニタリングデバイスは、体に穴を開けずに生理学的データを収集する医療デバイスです。血圧モニターやパルスオキシメーターなどのこれらのデバイスは、バイタルサインを追跡するために一般的に使用されます。

欧州心臓ネットワークによると、心臓血管疾患（CVD）は欧州で約390万人、欧州連合（EU）で180万人以上の死亡原因となっています。さらに中国では、2016年にCVDが農村部と都市部でそれぞれ総死亡の45.50％と43.16％を占めています。

慢性疾患の有病率の上昇

これらの疾患の罹患率は上昇を続けており、効率的で便利なモニタリングソリューションに対する需要が高まっています。非侵襲的デバイスは、侵襲的な処置を必要とせずにバイタルサインを継続的に追跡する重要な手段を提供し、早期発見と予防医療を重視する現代の医療に合致しています。この動向は市場を前進させ、進化する医療情勢と慢性疾患患者の増大するニーズに対応するため、非侵襲的モニタリングデバイスの技術革新と技術進歩を促進します。

高い初期費用

高度な技術の開発、製造、導入には多額の投資が必要となることが多いです。この経済的障壁は、特に予算に制約のある医療システムにおいて、非侵襲的モニタリングデバイスの普及を制限する可能性があります。医療機関にとってコスト要因は極めて重要な検討事項となり、高度なモニタリング・ソリューションへの投資能力を阻害します。この制約に対処するための取り組みとしては、戦略的な価格設定モデル、製造コスト削減のための協力、医療提供者と患者の双方にとって非侵襲的モニタリングデバイスを経済的に実行可能なものにするための有利な償還政策の提唱などが考えられます。

医療アクセスを促進する政府の取り組み

特に発展途上地域において、医療のインフラとアクセシビリティの向上を優先する政策やプログラムは、非侵襲的モニタリングデバイスの採用に資する環境を促進します。政府が公衆衛生の成果を向上させ、医療システムの負担軽減に努める中、患者の遠隔モニタリングや在宅ケアを可能にする技術を支援する傾向が強まっています。このような政府の医療政策との整合性は、市場範囲を拡大するだけでなく、非侵襲的モニタリングソリューションの広範な医療フレームワークへの統合を促し、全体的な患者ケアと転帰を向上させる。

データセキュリティへの懸念

これらのデバイスは機密性の高い医療データを収集・送信するため、不正アクセスやデータ漏洩のリスクは医療プロバイダーと患者の双方にとって大きな懸念事項です。患者情報の漏洩が発生すると、この技術に対する信頼が損なわれ、普及の妨げとなります。この脅威を軽減するには、厳格な暗号化プロトコル、強固なサイバーセキュリティ対策、プライバシー規制の遵守が必要です。この市場で事業を展開する企業は、安全でコンプライアンスに準拠したソリューションの開発を優先する必要があり、医療利害関係者は、進化する非侵襲的モニタリングの状況において患者データを保護するための対策を実施することに警戒を怠らない必要があります。

COVID-19の影響：

COVID-19の流行は市場にプラスの影響を与えました。パンデミックの間、患者モニタリングへの注目が高まり、遠隔医療ソリューションの必要性が高まったことで、非侵襲モニタリングデバイスの採用が加速しました。在宅医療や遠隔医療が重視されるようになり、病院への受診が減少したため、これらのデバイスは患者のバイタルサインを遠隔でモニタリングするのに不可欠なものとなった。パンデミックは、早期発見と継続的モニタリングの重要性を強調し、従来の医療環境以外でも健康パラメータを追跡する効果的で便利な方法を提供する非侵襲的ソリューションへの需要を促進しました。

予測期間中は血圧モニターが最大となる見込み

血圧モニターは市場で大きなシェアを占めています。高血圧と心血管疾患の世界の有病率の上昇に伴い、正確で便利な血圧モニタリングソリューションの需要が急増しています。技術の進歩により、ユーザーフレンドリーでポータブルなデバイスが開発され、臨床現場と家庭用の両方で採用が増加しています。デジタル機能の統合、ワイヤレス接続、モバイルヘルスアプリケーションとの互換性により、非侵襲的モニタリングにおける血圧モニターの魅力はさらに高まっています。

予測期間中、病院セグメントが最も高いCAGRが見込まれる

予測期間中、市場内で最もCAGRが高いのは病院です。バイタルサインモニターからウェアラブル健康トラッカーに至るまで、非侵襲的モニタリングデバイスは、侵襲的な処置なしに患者の健康を継続的に追跡する効率的な手段を病院に提供します。遠隔患者モニタリングの重視と非侵襲的デバイスの病院ワークフローへの統合は、患者ケアの改善、タイムリーな介入、医療提供の合理化に寄与します。病院が近代化と患者中心のケアを優先する中、非侵襲的モニタリングデバイスへの需要は伸び続け、医療業務の将来を形成しています。

最大のシェアを占める地域

北米は重要な位置を占めており、予測期間中も最大シェアを維持する見込みです。同地域の高度な医療インフラと研究開発の活発さが、非侵襲的モニタリング技術の革新を促進しています。予防医療に対する医療の意識の高まりや慢性疾患の高い有病率が、こうしたデバイスの需要に寄与しています。さらに、政府の支援政策、高齢化人口の増加、先進医療技術の採用が市場をさらに後押ししています。北米には主要な市場参入企業が存在し、戦略的協力関係も構築されていることから、非侵襲的モニタリングデバイス市場の軌道形成において主導的な役割を果たしています。

CAGRが最も高い地域：

アジア太平洋は、医療インフラの拡大と技術的進歩の重視の高まりによって、市場で最も高いCAGRを確認した。この地域は人口が多く多様性に富んでおり、医療に対する意識の高まりと相まって、非侵襲的モニタリングソリューションに対する需要を促進しています。アジア太平洋諸国の政府は医療への投資を増やしており、市場の成長を促進しています。慢性疾患の有病率の増加や在宅医療へのシフトは、非侵襲的デバイスの採用をさらに後押ししています。その結果、アジア太平洋は、非侵襲的モニタリング技術の進化における重要な貢献者、革新者として台頭してきています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます。

企業プロファイル
- 追加市場参入企業の包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推定・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

イントロダクション
北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他の欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他のアジア太平洋
南米
- アルゼンチン
- ブラジル
- チリ
- その他の南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他の中東とアフリカ

第9章主要発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第10章企業プロファイル

A&D Medical
Imacor
Abbott
Baxter
Koninklijke Philips N.V.
CAS Medical Systems
Conmed Corporation
Deltex Medical Limited
General Electric
Medtronic
Vaso Corporation
Omron

図表

List of Tables

Table 1 Global Non Invasive Monitoring Device Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Non Invasive Monitoring Device Market Outlook, By Type (2021-2030) ($MN)
Table 3 Global Non Invasive Monitoring Device Market Outlook, By Cardiac Monitors (2021-2030) ($MN)
Table 4 Global Non Invasive Monitoring Device Market Outlook, By Blood Pressure Monitor (2021-2030) ($MN)
Table 5 Global Non Invasive Monitoring Device Market Outlook, By Anaesthesia Monitor (2021-2030) ($MN)
Table 6 Global Non Invasive Monitoring Device Market Outlook, By Elecrtocardiagraph Monitor (2021-2030) ($MN)
Table 7 Global Non Invasive Monitoring Device Market Outlook, By Brain Monitor (2021-2030) ($MN)
Table 8 Global Non Invasive Monitoring Device Market Outlook, By Blood Glucose Monitor (2021-2030) ($MN)
Table 9 Global Non Invasive Monitoring Device Market Outlook, By Other Types (2021-2030) ($MN)
Table 10 Global Non Invasive Monitoring Device Market Outlook, By Indication (2021-2030) ($MN)
Table 11 Global Non Invasive Monitoring Device Market Outlook, By Hypertension (2021-2030) ($MN)
Table 12 Global Non Invasive Monitoring Device Market Outlook, By Heart Failure (2021-2030) ($MN)
Table 13 Global Non Invasive Monitoring Device Market Outlook, By Coronary Diseases (2021-2030) ($MN)
Table 14 Global Non Invasive Monitoring Device Market Outlook, By Myocardial Ischemia and Infarction (2021-2030) ($MN)
Table 15 Global Non Invasive Monitoring Device Market Outlook, By Arrhythmias (2021-2030) ($MN)
Table 16 Global Non Invasive Monitoring Device Market Outlook, By Congenital Problems (2021-2030) ($MN)
Table 17 Global Non Invasive Monitoring Device Market Outlook, By Other Indications (2021-2030) ($MN)
Table 18 Global Non Invasive Monitoring Device Market Outlook, By End User (2021-2030) ($MN)
Table 19 Global Non Invasive Monitoring Device Market Outlook, By Hospitals (2021-2030) ($MN)
Table 20 Global Non Invasive Monitoring Device Market Outlook, By Emergency Services Centers (2021-2030) ($MN)
Table 21 Global Non Invasive Monitoring Device Market Outlook, By Homecare (2021-2030) ($MN)
Table 22 Global Non Invasive Monitoring Device Market Outlook, By Other End Users (2021-2030) ($MN)
Table 23 North America Non Invasive Monitoring Device Market Outlook, By Country (2021-2030) ($MN)
Table 24 North America Non Invasive Monitoring Device Market Outlook, By Type (2021-2030) ($MN)
Table 25 North America Non Invasive Monitoring Device Market Outlook, By Cardiac Monitors (2021-2030) ($MN)
Table 26 North America Non Invasive Monitoring Device Market Outlook, By Blood Pressure Monitor (2021-2030) ($MN)
Table 27 North America Non Invasive Monitoring Device Market Outlook, By Anaesthesia Monitor (2021-2030) ($MN)
Table 28 North America Non Invasive Monitoring Device Market Outlook, By Elecrtocardiagraph Monitor (2021-2030) ($MN)
Table 29 North America Non Invasive Monitoring Device Market Outlook, By Brain Monitor (2021-2030) ($MN)
Table 30 North America Non Invasive Monitoring Device Market Outlook, By Blood Glucose Monitor (2021-2030) ($MN)
Table 31 North America Non Invasive Monitoring Device Market Outlook, By Other Types (2021-2030) ($MN)
Table 32 North America Non Invasive Monitoring Device Market Outlook, By Indication (2021-2030) ($MN)
Table 33 North America Non Invasive Monitoring Device Market Outlook, By Hypertension (2021-2030) ($MN)
Table 34 North America Non Invasive Monitoring Device Market Outlook, By Heart Failure (2021-2030) ($MN)
Table 35 North America Non Invasive Monitoring Device Market Outlook, By Coronary Diseases (2021-2030) ($MN)
Table 36 North America Non Invasive Monitoring Device Market Outlook, By Myocardial Ischemia and Infarction (2021-2030) ($MN)
Table 37 North America Non Invasive Monitoring Device Market Outlook, By Arrhythmias (2021-2030) ($MN)
Table 38 North America Non Invasive Monitoring Device Market Outlook, By Congenital Problems (2021-2030) ($MN)
Table 39 North America Non Invasive Monitoring Device Market Outlook, By Other Indications (2021-2030) ($MN)
Table 40 North America Non Invasive Monitoring Device Market Outlook, By End User (2021-2030) ($MN)
Table 41 North America Non Invasive Monitoring Device Market Outlook, By Hospitals (2021-2030) ($MN)
Table 42 North America Non Invasive Monitoring Device Market Outlook, By Emergency Services Centers (2021-2030) ($MN)
Table 43 North America Non Invasive Monitoring Device Market Outlook, By Homecare (2021-2030) ($MN)
Table 44 North America Non Invasive Monitoring Device Market Outlook, By Other End Users (2021-2030) ($MN)
Table 45 Europe Non Invasive Monitoring Device Market Outlook, By Country (2021-2030) ($MN)
Table 46 Europe Non Invasive Monitoring Device Market Outlook, By Type (2021-2030) ($MN)
Table 47 Europe Non Invasive Monitoring Device Market Outlook, By Cardiac Monitors (2021-2030) ($MN)
Table 48 Europe Non Invasive Monitoring Device Market Outlook, By Blood Pressure Monitor (2021-2030) ($MN)
Table 49 Europe Non Invasive Monitoring Device Market Outlook, By Anaesthesia Monitor (2021-2030) ($MN)
Table 50 Europe Non Invasive Monitoring Device Market Outlook, By Elecrtocardiagraph Monitor (2021-2030) ($MN)
Table 51 Europe Non Invasive Monitoring Device Market Outlook, By Brain Monitor (2021-2030) ($MN)
Table 52 Europe Non Invasive Monitoring Device Market Outlook, By Blood Glucose Monitor (2021-2030) ($MN)
Table 53 Europe Non Invasive Monitoring Device Market Outlook, By Other Types (2021-2030) ($MN)
Table 54 Europe Non Invasive Monitoring Device Market Outlook, By Indication (2021-2030) ($MN)
Table 55 Europe Non Invasive Monitoring Device Market Outlook, By Hypertension (2021-2030) ($MN)
Table 56 Europe Non Invasive Monitoring Device Market Outlook, By Heart Failure (2021-2030) ($MN)
Table 57 Europe Non Invasive Monitoring Device Market Outlook, By Coronary Diseases (2021-2030) ($MN)
Table 58 Europe Non Invasive Monitoring Device Market Outlook, By Myocardial Ischemia and Infarction (2021-2030) ($MN)
Table 59 Europe Non Invasive Monitoring Device Market Outlook, By Arrhythmias (2021-2030) ($MN)
Table 60 Europe Non Invasive Monitoring Device Market Outlook, By Congenital Problems (2021-2030) ($MN)
Table 61 Europe Non Invasive Monitoring Device Market Outlook, By Other Indications (2021-2030) ($MN)
Table 62 Europe Non Invasive Monitoring Device Market Outlook, By End User (2021-2030) ($MN)
Table 63 Europe Non Invasive Monitoring Device Market Outlook, By Hospitals (2021-2030) ($MN)
Table 64 Europe Non Invasive Monitoring Device Market Outlook, By Emergency Services Centers (2021-2030) ($MN)
Table 65 Europe Non Invasive Monitoring Device Market Outlook, By Homecare (2021-2030) ($MN)
Table 66 Europe Non Invasive Monitoring Device Market Outlook, By Other End Users (2021-2030) ($MN)
Table 67 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Country (2021-2030) ($MN)
Table 68 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Type (2021-2030) ($MN)
Table 69 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Cardiac Monitors (2021-2030) ($MN)
Table 70 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Blood Pressure Monitor (2021-2030) ($MN)
Table 71 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Anaesthesia Monitor (2021-2030) ($MN)
Table 72 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Elecrtocardiagraph Monitor (2021-2030) ($MN)
Table 73 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Brain Monitor (2021-2030) ($MN)
Table 74 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Blood Glucose Monitor (2021-2030) ($MN)
Table 75 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Other Types (2021-2030) ($MN)
Table 76 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Indication (2021-2030) ($MN)
Table 77 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Hypertension (2021-2030) ($MN)
Table 78 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Heart Failure (2021-2030) ($MN)
Table 79 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Coronary Diseases (2021-2030) ($MN)
Table 80 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Myocardial Ischemia and Infarction (2021-2030) ($MN)
Table 81 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Arrhythmias (2021-2030) ($MN)
Table 82 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Congenital Problems (2021-2030) ($MN)
Table 83 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Other Indications (2021-2030) ($MN)
Table 84 Asia Pacific Non Invasive Monitoring Device Market Outlook, By End User (2021-2030) ($MN)
Table 85 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Hospitals (2021-2030) ($MN)
Table 86 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Emergency Services Centers (2021-2030) ($MN)
Table 87 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Homecare (2021-2030) ($MN)
Table 88 Asia Pacific Non Invasive Monitoring Device Market Outlook, By Other End Users (2021-2030) ($MN)
Table 89 South America Non Invasive Monitoring Device Market Outlook, By Country (2021-2030) ($MN)
Table 90 South America Non Invasive Monitoring Device Market Outlook, By Type (2021-2030) ($MN)
Table 91 South America Non Invasive Monitoring Device Market Outlook, By Cardiac Monitors (2021-2030) ($MN)
Table 92 South America Non Invasive Monitoring Device Market Outlook, By Blood Pressure Monitor (2021-2030) ($MN)
Table 93 South America Non Invasive Monitoring Device Market Outlook, By Anaesthesia Monitor (2021-2030) ($MN)
Table 94 South America Non Invasive Monitoring Device Market Outlook, By Elecrtocardiagraph Monitor (2021-2030) ($MN)
Table 95 South America Non Invasive Monitoring Device Market Outlook, By Brain Monitor (2021-2030) ($MN)
Table 96 South America Non Invasive Monitoring Device Market Outlook, By Blood Glucose Monitor (2021-2030) ($MN)
Table 97 South America Non Invasive Monitoring Device Market Outlook, By Other Types (2021-2030) ($MN)
Table 98 South America Non Invasive Monitoring Device Market Outlook, By Indication (2021-2030) ($MN)
Table 99 South America Non Invasive Monitoring Device Market Outlook, By Hypertension (2021-2030) ($MN)
Table 100 South America Non Invasive Monitoring Device Market Outlook, By Heart Failure (2021-2030) ($MN)
Table 101 South America Non Invasive Monitoring Device Market Outlook, By Coronary Diseases (2021-2030) ($MN)
Table 102 South America Non Invasive Monitoring Device Market Outlook, By Myocardial Ischemia and Infarction (2021-2030) ($MN)
Table 103 South America Non Invasive Monitoring Device Market Outlook, By Arrhythmias (2021-2030) ($MN)
Table 104 South America Non Invasive Monitoring Device Market Outlook, By Congenital Problems (2021-2030) ($MN)
Table 105 South America Non Invasive Monitoring Device Market Outlook, By Other Indications (2021-2030) ($MN)
Table 106 South America Non Invasive Monitoring Device Market Outlook, By End User (2021-2030) ($MN)
Table 107 South America Non Invasive Monitoring Device Market Outlook, By Hospitals (2021-2030) ($MN)
Table 108 South America Non Invasive Monitoring Device Market Outlook, By Emergency Services Centers (2021-2030) ($MN)
Table 112 South America Non Invasive Monitoring Device Market Outlook, By Homecare (2021-2030) ($MN)
Table 113 South America Non Invasive Monitoring Device Market Outlook, By Other End Users (2021-2030) ($MN)
Table 114 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Country (2021-2030) ($MN)
Table 115 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Type (2021-2030) ($MN)
Table 116 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Cardiac Monitors (2021-2030) ($MN)
Table 117 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Blood Pressure Monitor (2021-2030) ($MN)
Table 118 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Anaesthesia Monitor (2021-2030) ($MN)
Table 119 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Elecrtocardiagraph Monitor (2021-2030) ($MN)
Table 120 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Brain Monitor (2021-2030) ($MN)
Table 121 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Blood Glucose Monitor (2021-2030) ($MN)
Table 122 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Other Types (2021-2030) ($MN)
Table 123 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Indication (2021-2030) ($MN)
Table 124 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Hypertension (2021-2030) ($MN)
Table 125 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Heart Failure (2021-2030) ($MN)
Table 126 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Coronary Diseases (2021-2030) ($MN)
Table 127 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Myocardial Ischemia and Infarction (2021-2030) ($MN)
Table 128 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Arrhythmias (2021-2030) ($MN)
Table 129 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Congenital Problems (2021-2030) ($MN)
Table 130 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Other Indications (2021-2030) ($MN)
Table 131 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By End User (2021-2030) ($MN)
Table 132 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Hospitals (2021-2030) ($MN)
Table 133 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Emergency Services Centers (2021-2030) ($MN)
Table 134 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Homecare (2021-2030) ($MN)
Table 135 Middle East & Africa Non Invasive Monitoring Device Market Outlook, By Other End Users (2021-2030) ($MN)

Product Code: SMRC24430

According to Stratistics MRC, the Global Non Invasive Monitoring Device Market is accounted for $4.4 billion in 2023 and is expected to reach $9.1 billion by 2030 growing at a CAGR of 10.8% during the forecast period. A non-invasive monitoring device is a medical instrument that gathers physiological data without penetrating the body. These devices, such as blood pressure monitors or pulse oximeters, are commonly used to track vital signs.

According to the European Heart Network, Cardiovascular Diseases (CVDs) have been a cause of ~3.9 million deaths in Europe and more than 1.8 million deaths in the European Union (EU). Further, in China, CVDs led to 45.50% and 43.16% of total death in rural areas and urban areas, respectively, in 2016.

Market Dynamics:

Driver:

The rising prevalence of chronic diseases

The incidence of these conditions continues to rise, there is a growing demand for efficient and convenient monitoring solutions. Non-invasive devices provide a crucial means to continuously track vital signs without the need for invasive procedures, aligning with the contemporary healthcare emphasis on early detection and preventative care. This trend propels the market forward, fostering innovation and technological advancements in non-invasive monitoring devices to address the evolving healthcare landscape and the increasing needs of patients with chronic illnesses.

Restraint:

High initial costs

The development, manufacturing and implementation of sophisticated technologies often require substantial investments. This financial barrier can limit the widespread adoption of non-invasive monitoring devices, particularly in healthcare systems with constrained budgets. The cost factor becomes a crucial consideration for healthcare institutions, hindering their ability to invest in advanced monitoring solutions. Efforts to address this restraint may involve strategic pricing models, collaborations to reduce production costs, and advocacy for favorable reimbursement policies to make non-invasive monitoring devices more economically viable for both providers and patients.

Opportunity:

Government initiatives to promote healthcare access

Policies and programs that prioritize enhanced healthcare infrastructure and accessibility, particularly in developing regions, foster a conducive environment for the adoption of non-invasive monitoring devices. As governments strive to improve public health outcomes and reduce the burden on healthcare systems, there is a growing inclination towards supporting technologies that enable remote patient monitoring and home-based care. This alignment with governmental healthcare agendas not only expands the market reach but also encourages the integration of non-invasive monitoring solutions into broader healthcare frameworks, enhancing overall patient care and outcomes.

Threat:

Data security concerns

These devices collect and transmit sensitive health data, the risk of unauthorized access and data breaches is a major apprehension for both healthcare providers and patients. Instances of compromised patient information can erode trust in the technology and impede widespread adoption. Mitigating this threat requires stringent encryption protocols, robust cybersecurity measures, and adherence to privacy regulations. Companies operating in this market must prioritize the development of secure and compliant solutions, and healthcare stakeholders should stay vigilant in implementing measures to safeguard patient data in the evolving landscape of non-invasive monitoring.

COVID-19 Impact:

The COVID-19 pandemic has positively impacted the market. The heightened focus on patient monitoring and the need for remote healthcare solutions during the pandemic accelerated the adoption of non-invasive monitoring devices. With an increased emphasis on home-based care and telemedicine to reduce hospital visits, these devices have become integral in monitoring patients' vital signs remotely. The pandemic underscored the importance of early detection and continuous monitoring, driving the demand for non-invasive solutions that provide effective and convenient ways to track health parameters outside traditional healthcare settings.

The blood pressure monitor is expected to be the largest during the forecast period

The blood pressure monitor has a significant share in the market. With a rising global prevalence of hypertension and cardiovascular diseases, the demand for accurate and convenient blood pressure monitoring solutions has surged. Technological advancements have led to the development of user-friendly and portable devices, contributing to increased adoption both in clinical settings and for home use. The integration of digital features, wireless connectivity, and compatibility with mobile health applications further enhances the appeal of blood pressure monitors in the non-invasive monitoring landscape.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals have the highest CAGR within the market over the forecast period. Non-invasive monitoring devices, ranging from vital sign monitors to wearable health trackers, offer hospitals efficient means to continuously track patients' health without invasive procedures. The emphasis on remote patient monitoring and the integration of non-invasive devices into hospital workflows contribute to improved patient care, timely interventions, and streamlined healthcare delivery. As hospitals prioritize modernization and patient-centric care, the demand for non-invasive monitoring devices continues to grow, shaping the future of healthcare practices.

Region with largest share:

North America holds a significant position and expected to hold a largest share over the forecast period. The region's advanced healthcare infrastructure, coupled with robust research and development activities, drives innovation in non-invasive monitoring technologies. Increasing awareness of preventive healthcare and a high prevalence of chronic diseases contribute to the demand for these devices. Additionally, supportive government policies, a growing aging population, and the adoption of advanced healthcare technologies further propel the market. The presence of key market players and strategic collaborations in North America solidify its leadership role in shaping the trajectory of the Non-Invasive Monitoring Device Market.

Region with highest CAGR:

The Asia-Pacific region witnessed the highest CAGR in the market, driven by expanding healthcare infrastructure and a growing emphasis on technological advancements. The region's large and diverse population, coupled with rising healthcare awareness, fuels the demand for non-invasive monitoring solutions. Governments in several Asia Pacific countries are increasingly investing in healthcare, fostering market growth. The increasing prevalence of chronic diseases and a shift toward home healthcare further boost the adoption of non-invasive devices. As a result, Asia Pacific is emerging as a key contributor and innovator in the evolving landscape of non-invasive monitoring technologies.

Key players in the market:

Some of the key players in Non Invasive Monitoring Device Market include A&D Medical, Imacor, Abbott, Baxter, Koninklijke Philips N.V., CAS Medical Systems, Conmed Corporation, Deltex Medical Limited, General Electric, Medtronic, Vaso Corporation and Omron.

Key Developments:

In October 2023, Baxter International Inc. (NYSE:BAX) announced the launch of digital image capture capability for eye exams using its existing Welch Allyn PanOptic Plus Ophthalmoscope.

In October 2023, Royal Philips a global leader in health technology announced it has received a second round of funding from the Bill & Melinda Gates Foundation to accelerate global adoption of AI algorithms on Philips Lumify Handheld Ultrasound.

Types Covered:

Cardiac Monitors
Blood Pressure Monitor
Anaesthesia Monitor
Electrocardiograph Monitor
Brain Monitor
Blood Glucose Monitor
Other Types

Indications Covered:

Hypertension
Heart Failure
Coronary Diseases
Myocardial Ischemia and Infarction
Arrhythmias
Congenital Problems
Other Indications

End Users Covered:

Hospitals
Emergency Services Centers
Homecare
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Non Invasive Monitoring Device Market, By Type

5.1 Introduction
5.2 Cardiac Monitors
5.3 Blood Pressure Monitor
5.4 Anaesthesia Monitor
5.5 Elecrtocardiagraph Monitor
5.6 Brain Monitor
5.7 Blood Glucose Monitor
5.8 Other Types

6 Global Non Invasive Monitoring Device Market, By Indication

6.1 Introduction
6.2 Hypertension
6.3 Heart Failure
6.4 Coronary Diseases
6.5 Myocardial Ischemia and Infarction
6.6 Arrhythmias
6.7 Congenital Problems
6.8 Other Indications

7 Global Non Invasive Monitoring Device Market, By End User

7.1 Introduction
7.2 Hospitals
7.3 Emergency Services Centers
7.4 Homecare
7.5 Other End Users

8 Global Non Invasive Monitoring Device Market, By Geography

8.1 Introduction
8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa

9 Key Developments

9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling

10.1 A&D Medical
10.2 Imacor
10.3 Abbott
10.4 Baxter
10.5 Koninklijke Philips N.V.
10.6 CAS Medical Systems
10.7 Conmed Corporation
10.8 Deltex Medical Limited
10.9 General Electric
10.10 Medtronic
10.11 Vaso Corporation
10.12 Omron

非侵襲的モニタリングデバイス市場の2030年までの予測：タイプ別、適応症別、エンドユーザー別、地域別の世界分析

Non Invasive Monitoring Device Market Forecasts to 2030 - Global Analysis By Type, By Indication, By End User and By Geography

COVID-19の影響：

最大のシェアを占める地域

CAGRが最も高い地域：

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の非侵襲的モニタリングデバイス市場：タイプ別

第6章 世界の非侵襲的モニタリングデバイス市場：適応症別

第7章 世界の非侵襲的モニタリングデバイス市場：エンドユーザー別

第8章 世界の非侵襲的モニタリングデバイス市場：地域別

第9章 主要発展

第10章 企業プロファイル